Anthropometric Measurements as Predictors of Low Birth Weight Among Tanzanian Neonates: A Hospital-Based Study
November 7, 2025
Brand Name :
Iomeron
Synonyms :
iomeprol
Class :
Radiological, Iodinated contrast media
Dosage Forms & StrengthsÂ
Solution for injectionÂ
250mg/mlÂ
300mg/mlÂ
400mg/mlÂ
Angiocardiography & left ventriculography
From single-use containers, take 300 or 350, or 400 mg/ml iodine
30-80 ml intra-arterially, keep maximum dose upto 250 ml
Aortography
From single-use containers, take 350 or 400 mg/ml of iodine
50-80 ml intra-arterially
Cerebral Arteriography
From single-use containers, take 250 or 300 mg/ml of iodine
5-12 ml intra-arterially
Repeat if required
Coronary Arteriography
From single-use containers, take 350 or 400 mg/ml of iodine
4-10 ml intra-arterially
Repeat if required
Peripheral Arteriography
From single-use containers, take 300 or 350 mg/ml of iodine
5-12 ml intra-arterially
Repeat if required
Computed Tomography
Brain CT Scan- Use 250 or 300, or 350 mg/ml iodine intravenously from single-use containers
300 or 350 mg/ml from multi-dose containers
Whole body CT- Use 250 or 300, 350, or 400 mg/ml iodine intravenously from single-use containers
300, 350, or 400 mg/ml from multi-dose containers
Urography
Use 250, 300, 350, or 400 mg/ml iodine intravenously from single-use containers
Keep a maximum of 50-150 ml
Angiocardiography & left ventriculography
From single-use containers, take 300 or 350, or 400 mg/ml iodine
30-80 ml intra-arterially, keep maximum dose upto 250 ml
Aortography
From single-use containers, take 350 or 400 mg/ml of iodine
50-80 ml intra-arterially
Cerebral Arteriography
From single-use containers, take 250 or 300 mg/ml of iodine
5-12 ml intra-arterially
Repeat if required
Coronary Arteriography
From single-use containers, take 350 or 400 mg/ml of iodine
4-10 ml intra-arterially
Repeat if required
Peripheral Arteriography
From single-use containers, take 300 or 350 mg/ml of iodine
5-12 ml intra-arterially
Repeat if required
Computed Tomography
Brain CT Scan- Use 250 or 300, or 350 mg/ml iodine intravenously from single-use containers
300 or 350 mg/ml from multi-dose containers
Whole body CT- Use 250 or 300, 350, or 400 mg/ml iodine intravenously from single-use containers
300, 350, or 400 mg/ml from multi-dose containers
Urography
Use 250, 300, 350, or 400 mg/ml iodine intravenously from single-use containers
Keep a maximum of 50-150 ml
No data is available Â
Refer to the adult dosingÂ
seizure lowering agents increase the toxic or adverse effects of iomeprol
seizure lowering agents increase the toxic or adverse effects of iomeprol
seizure lowering agents increase the toxic or adverse effects of iomeprol
seizure lowering agents increase the toxic or adverse effects of iomeprol
seizure lowering agents increase the toxic or adverse effects of iomeprol
Actions and SpectrumÂ
Actions:Â
iomeprol works by containing iodine, which is a high-atomic-number element that effectively absorbs X-rays. When administered into the body, it increases the contrast or brightness of blood vessels and specific organs during imaging procedures. This increased contrast allows healthcare professionals to better visualize and differentiate structures within the body, aiding in diagnosing and assessing various medical conditions.Â
Spectrum:Â
iomeprol has a broad X-ray absorption spectrum, meaning it absorbs X-rays across a range of energy levels. This absorption spectrum makes it suitable for various imaging techniques, including routine CT scans, angiograms, and other radiographic procedures. Â
Frequency definedÂ
>10%Â
HeadacheÂ
1-10%Â
HypertensionÂ
VomitingÂ
NauseaÂ
Feeling hotÂ
DizzinessÂ
Limb painÂ
Back painÂ
<1%Â
TachycardiaÂ
PruritisÂ
ErythemaÂ
DyspneaÂ
FeverÂ
Increased serum creatinineÂ
Muscle rigidityÂ
AstheniaÂ
Black Box Warning:Â
NoneÂ
Contraindication/Caution:Â
Contraindications:Â
Cautions:Â
Pregnancy consideration:Â Â
The drug crosses the placenta, hence should be avoided during pregnancy.Â
Breastfeeding warnings:Â Â
iomeprol is excreted in small amounts in breast milk; hence, utilize it cautiously.Â
Pregnancy category:Â
Category A: well-controlled and satisfactory studies show no risk to the fetus in the first or later trimester.Â
Category B: there was no evidence of risk to the fetus in animal studies, and there were not enough studies on pregnant women.Â
Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.   Â
Category D: adequate data with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.   Â
Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.   Â
Category N: No data is available for the drug under this category.Â
Pharmacology:Â Â
iomeprol is an iodinated contrast agent used in medical imaging to enhance the visibility of blood vessels and tissues during radiographic procedures such as computed tomography (CT) scans and angiography. It works by taking advantage of the high atomic number of iodine, which effectively absorbs X-rays. When administered into the body, iomeprol increases the contrast or brightness of the structures it fills, allowing them to be more clearly visualized in the resulting images.Â
Pharmacodynamics:Â
The primary pharmacodynamic effect of iomeprol is the enhancement of contrast in medical images. Contrast refers to the difference in X-ray absorption between different tissues or structures within the body. Because iomeprol absorbs X-rays more readily than the surrounding tissues, it increases the contrast between blood vessels and other structures, making them more visible in the resulting images.Â
Pharmacokinetics:Â
AbsorptionÂ
When administered intravenously, iomeprol is absorbed systemically.Â
DistributionÂ
After intravenous administration, iomeprol is rapidly distributed throughout the body’s blood vessels and extracellular spaces.Â
MetabolismÂ
iomeprol is minimally metabolized in the body.Â
Elimination and excretionÂ
The elimination half-life is 1.9 hoursÂ
It is excreted through the kidneysÂ
Administration:Â
Patient information leafletÂ
Generic Name: iomeprolÂ
Pronounced as: i-ome-prolÂ
Why do we use iomeprol?Â